v3.26.1
Goodwill and Other Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Finite-Lived Intangible Assets [Line Items]    
Intangible assets, net $ 185,598,287 $ 189,341,387 [1]
Exclusive Licensing Agreement    
Finite-Lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets 96,000,000 96,000,000
Total Patents & Other Intangible Assets    
Finite-Lived Intangible Assets [Line Items]    
Total Patents & Other Intangible Assets, Gross 453,611,347 456,353,346
Total Patents & Other Intangible Assets, Accumulated Amortization (257,029,148) (256,001,006)
Total Patents & Other Intangible Assets, Net 196,582,199 200,352,340
Gentex Patents    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross 39,939,006 39,769,415
Accumulated Amortization (28,955,094) (28,758,462)
Finite-lived intangible assets, net 10,983,912 11,010,953
Total Other Intangible Assets    
Finite-Lived Intangible Assets [Line Items]    
Accumulated Amortization (228,074,054) (227,242,544)
Intangible assets, gross 413,672,341 416,583,931
Intangible assets, net 185,598,287 189,341,387
Existing Customer Platforms    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross 43,000,000 43,000,000
Accumulated Amortization (43,000,000) (43,000,000)
Finite-lived intangible assets, net $ 0 $ 0
Assumed Useful Life 10 years 10 years
HomeLink® | Trade names and trademarks    
Finite-Lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets $ 52,000,000 $ 52,000,000
HomeLink® | Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross 180,000,000 180,000,000
Accumulated Amortization (180,000,000) (180,000,000)
Finite-lived intangible assets, net $ 0 $ 0
Assumed Useful Life 12 years 12 years
BioCenturion | Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross $ 2,300,000 $ 2,300,000
Accumulated Amortization (271,528) (223,611)
Finite-lived intangible assets, net $ 2,028,472 $ 2,076,389
Assumed Useful Life 12 years 12 years
BioCenturion | Trade names and trademarks    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross $ 640,000 $ 640,000
Accumulated Amortization (90,667) (74,667)
Finite-lived intangible assets, net $ 549,333 $ 565,333
Assumed Useful Life 10 years 10 years
eSight | Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross $ 12,000,000 $ 12,000,000
Accumulated Amortization (2,416,667) (2,166,667)
Finite-lived intangible assets, net $ 9,583,333 $ 9,833,333
Assumed Useful Life 12 years 12 years
eSight | Trade names and trademarks    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross $ 870,000 $ 870,000
Accumulated Amortization (175,208) (157,083)
Finite-lived intangible assets, net $ 694,792 $ 712,917
Assumed Useful Life 12 years 12 years
BioConnect | Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross $ 5,392,068 $ 5,465,061
Accumulated Amortization (351,578) (241,908)
Finite-lived intangible assets, net $ 5,040,490 $ 5,223,153
Assumed Useful Life 12 years 12 years
BioConnect | Trade names and trademarks    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross $ 861,454 $ 874,320
Accumulated Amortization (56,169) (32,254)
Finite-lived intangible assets, net $ 805,285 $ 842,066
Assumed Useful Life 12 years 12 years
BioConnect | Customer Relationships    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross $ 1,722,909 $ 1,748,640
Accumulated Amortization (112,338) (77,411)
Finite-lived intangible assets, net $ 1,610,571 $ 1,671,229
Assumed Useful Life 10 years 10 years
Vaporsens, Inc. | In-Process R&D    
Finite-Lived Intangible Assets [Line Items]    
Indefinite-lived intangible assets $ 3,000,000 $ 5,800,000
Argil | Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross 6,278,132 6,278,132
Accumulated Amortization (261,589) (130,794)
Finite-lived intangible assets, net $ 6,016,543 $ 6,147,338
Assumed Useful Life 12 years 12 years
Air-CraftGlass | Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross $ 1,507,778 $ 1,507,778
Accumulated Amortization (157,060) (125,649)
Finite-lived intangible assets, net $ 1,350,718 $ 1,382,129
Assumed Useful Life 12 years 12 years
Guardian | Developed technology    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross $ 6,800,000 $ 6,800,000
Accumulated Amortization (991,667) (850,000)
Finite-lived intangible assets, net $ 5,808,333 $ 5,950,000
Assumed Useful Life 12 years 12 years
Guardian | Trade names and trademarks    
Finite-Lived Intangible Assets [Line Items]    
Finite-lived intangible assets, gross $ 1,300,000 $ 1,300,000
Accumulated Amortization (189,583) (162,500)
Finite-lived intangible assets, net $ 1,110,417 $ 1,137,500
Assumed Useful Life 12 years 12 years
[1] The Condensed Consolidated Balance Sheet at December 31, 2025 has been derived from the audited Consolidated Financial Statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.